Evidence map›Paper›PMID 36599938›Full record

ArticleEuropean journal of human genetics : EJHG2023

CDK13-related disorder: a deep characterization of speech and language abilities and addition of 33 novel cases.

Lottie D Morison, Olivia van Reyk, Elana Forbes, Flavien Rouxel, Laurence Faivre, Fiona Bruinsma, Marie Vincent, Marie-Line Jacquemont, Natalie L Dykzeul, David Geneviève and 2 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Speech and language classification in the human phenotype ontology.European journal of human genetics : EJHG · 2024
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Lottie D MorisonSpeech and Language, Murdoch Children's Research Institute, Melbourne, VIC, Australia.ORCID 0000-0003-2822-6522
Olivia van ReykSpeech and Language, Murdoch Children's Research Institute, Melbourne, VIC, Australia.ORCID 0000-0001-7333-4384
Elana ForbesSpeech and Language, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Flavien RouxelGénétique Clinique, Départment de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CHU Montpellier, Montpellier University, Centre de Référence Anomalies du Développement SOOR, Montpellier, France.
Laurence FaivreCentre de Référence Anomalies du Développment et Syndromes Malformatifs, FHU TRANSLAD, CHU Dijon, Dijon, France.
Fiona BruinsmaCancer Council Victoria, Melbourne, VIC, Australia.
Marie VincentService de génétique médicale, CHU Nantes, 9 quai Moncousu, Nantes, France.ORCID 0000-0003-1010-5618
Marie-Line JacquemontUnit of Medical Genetics, CHU La Réunion, Saint Pierre, France.
Natalie L DykzeulLucile Packard Children's Hospital, Stanford Children's Health, Palo Alto, CA, USA.
David GenevièveGénétique Clinique, Départment de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CHU Montpellier, Montpellier University, Centre de Référence Anomalies du Développement SOOR, Montpellier, France.ORCID 0000-0001-6928-6287
David J AmorSpeech and Language, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Angela T MorganSpeech and Language, Murdoch Children's Research Institute, Melbourne, VIC, Australia. angela.morgan@mcri.edu.au.ORCID 0000-0003-1147-7405
Murdoch Children's Research Institute · AURoyal Children's Hospital · AUUniversité de Montpellier · FRCancer Council Victoria · AUGénétique Médicale & Génomique Fonctionelle · FRInserm · FRLucile Packard Children's Hospital · US

Funding

Department of Health | National Health and Medical Research Council (NHMRC) #1105008Department of Health | National Health and Medical Research Council (NHMRC) #1116976Department of Health | National Health and Medical Research Council (NHMRC) #1195955Department of Health | National Health and Medical Research Council (NHMRC) #APP1127144
6 · The paper itself

Abstract

Speech and language impairments are central features of CDK13-related disorder. While pathogenic CDK13 variants have been associated with childhood apraxia of speech (CAS), a systematic characterisation of communication has not been conducted. Here we examined speech, language, non-verbal communication skills, social behaviour and health and development in 41 individuals with CDK13-related disorder from 10 countries (male = 22, median-age 7 years 1 month, range 1-25 years; 33 novel). Most participants used augmentative and alternative communication (AAC) in early childhood (24/41). CAS was common (14/22). Performance varied widely across intellectual ability, social behaviour and expressive language skills, with participants ranging from within average through to the severely impaired range. Receptive language was significantly stronger than expressive language ability. Social motivation was a relative strength. In terms of a broader health phenotype, a quarter had one or more of: renal, urogenital, musculoskeletal, and cardiac malformations, vision impairment, ear infections and/or sleep disturbance. All had gross and fine motor impairments (41/41). Other conditions included mild-moderate intellectual disability (16/22) and autism (7/41). No genotype-phenotype correlations were found. Recognition of CAS, a rare speech disorder, is required to ensure appropriately targeted therapy. The high prevalence of speech and language impairment underscores the importance of tailored speech therapy, particularly early access to AAC supports.

Indexed as

ApraxiasIntellectual DisabilityLanguage Development DisordersCDC2 Protein KinaseChild, PreschoolCommunicationHumansLanguageMaleSpeechSpeech DisordersCDC2 Protein KinaseCDK13 protein, human

Identifiers

PMID36599938
PMCPMC10325997
OpenAlexW4313544376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.